In fact, even so-called non-responders may exhibit protection against joint destruction [44], illustrating that clinical responders and non-responders to anti-TNF therapy do not necessarily represent completely distinct pathogenetic subsets of RA. Here, TNF is linked to rheumatoid arthritis.